Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
about
Brain monoglyceride lipase participating in endocannabinoid inactivationEndocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alphaDelta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusCannabis and psychosis/schizophrenia: human studiesCB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesComplex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulationEndocannabinoid Signaling Regulates Sleep StabilityCannabinoid neuromodulation in the adult early visual cortexCannabinoids and psychosisRegulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memoryInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampusReduced gamma oscillations in a mouse model of intellectual disability: a role for impaired repetitive neurotransmission?Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiationNMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depressionThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisΔ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retentionThe effect of chronic cannabinoids on broadband EEG neural oscillations in humans.Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations.Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisCannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Modulation of gamma-aminobutyric acid type A receptor-mediated spontaneous inhibitory postsynaptic currents in auditory cortex by midazolam and isofluraneDentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy.Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brainQuantitative ultrastructural differences between local and medial septal GABAergic axon terminals in the rat hippocampus.Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairmentCannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsyEndocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Cell type-specific control of neuronal responsiveness by gamma-band oscillatory inhibition.Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneuronsEndocannabinoids in the dentate gyrus.Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells.Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia
P2860
Q24533828-625154D2-1DFA-456B-B128-0843857D59FDQ24564778-AE3A9535-1F52-4E3D-A6EA-3E321A71388EQ24597687-C09433BF-D72E-40C7-9A05-F3D9BD646DCCQ24628837-93FAF0A9-63A8-43D5-9D99-8D798CBE02D3Q24649936-C4EB0497-57AC-4FD2-95F6-5CAB8868BBE3Q27305122-5A564213-7E9A-433F-A000-FF43AEBD1087Q27316124-8A3FAFB0-6622-4983-A410-175520B0B83AQ27324757-1A09471D-0F50-4D93-B7E0-4CED38DC7BF9Q28241328-A83637B7-C8E5-4D6F-A2E5-106C386954FBQ28295045-D74076AF-654A-48FE-B8FB-A75CCA2DAB53Q28298445-0D05BBD4-2B67-49B7-B7CF-F8CB9B70B0C0Q28363366-99C643E7-FE07-4478-9533-4229770305F6Q28538532-AAD0632E-2EE5-4568-AA8F-E0FD44DA29FEQ28572677-23E9A864-4F75-40CA-AFF3-905C1C33ED7AQ28579836-45BD545A-BF50-4690-9D67-1D69EA19C1EDQ30047193-F7884EAD-9370-4489-92F4-2E94D2525274Q30377901-4216D94A-5E1D-4B6F-A8EE-46ABF2D4400BQ30392035-8160B1E2-D170-41D9-9AB3-A56554F3BD00Q30450059-583CE91D-BD48-4F43-ADE9-99E654DD5EE8Q30459343-C356B524-1D58-4FB4-8CB4-3428C2B91AF4Q30493991-12C0E543-E89A-4471-88BC-5215F99A152CQ30494037-AC98C612-2DA3-45B8-B230-9AD026660214Q30495206-CDDFE8E4-5D8D-46F5-94B2-92180F750C39Q30497212-F55AED02-4C86-4B4C-ADA7-85F0C4FA5BB2Q30499458-188A19AD-777A-4D11-BFCC-B6DB5D880DDDQ30724974-413DB269-65E4-4835-BE5A-79324AEC6FC1Q31095554-96BBBE30-AF37-4622-BC77-9EF71547F378Q33258602-2F5CB377-6F5B-4329-B546-00CD9A37D3EAQ33301407-F1F12653-9895-434E-80F2-43B535DE6F4FQ33562576-52F29318-5084-4765-8D2E-3F51E97459C4Q33586242-062D5412-1C73-465F-824C-1AE4CBE15882Q33621756-0606612B-B84C-4EE2-AEDA-EAC64BE23DB6Q33655408-0654ADCE-1C7C-4355-8315-E7295D7FA977Q33664684-302D5EDF-2EF4-4401-9F15-838810A845A2Q33668041-1B972905-F0A8-4080-AF62-84EA29A88EFBQ33745042-360705BA-7C5E-45AF-AF39-A5139C3263EDQ33757950-BF41364E-29F3-4E7F-8B7D-03AF6DB0748CQ33897801-61253BD9-713A-408C-959F-93EB4845A225Q33923685-69FE0075-9678-40EB-A13D-0C67436CDCC6Q33932087-65D4B7AB-0CBF-470F-A9CC-42A78D63B620
P2860
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@ast
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@en
type
label
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@ast
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@en
prefLabel
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@ast
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
@en
P2093
P2860
P50
P1476
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
@en
P2093
P2860
P304
P356
10.1046/J.1460-9568.2000.00217.X
P407
P577
2000-09-01T00:00:00Z